{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:38:34Z","timestamp":1790771914092,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10689-010-9320-2","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T08:49:18Z","timestamp":1263890958000},"page":"449-457","source":"Crossref","is-referenced-by-count":108,"title":["Update multiple endocrine neoplasia type 2"],"prefix":"10.1007","volume":"9","author":[{"given":"Friedhelm","family":"Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Frank-Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"9320_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JBJ, Healey CS et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a (MEN 2A). Nature 363:458\u2013469","journal-title":"Nature"},{"key":"9320_CR2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genetics 2:851\u2013856","journal-title":"Hum Mol Genetics"},{"key":"9320_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0889-8529(18)30121-X","volume":"23","author":"F Raue","year":"1994","unstructured":"Raue F, Frank-Raue K, Grauer A (1994) Multiple endocrine neoplasia type 2, clinical features and screening. Endocrin Metab Clin North Am 23:137\u2013156","journal-title":"Endocrin Metab Clin North Am"},{"key":"9320_CR4","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel R, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archinte.1992.00400180104016","volume":"152","author":"HF Vasen","year":"1992","unstructured":"Vasen HF, van der Feltz M, Raue F et al (1992) The natural course of multiple endocrine neoplasia type 2 b. Arch Intern Med 152:1250\u20131252","journal-title":"Arch Intern Med"},{"key":"9320_CR6","first-page":"770","volume":"83","author":"I Berndt","year":"1998","unstructured":"Berndt I, Reuter M, Saller B et al (1998) A new hotspot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83:770\u2013774","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565\u2013612","journal-title":"Thyroid"},{"key":"9320_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","volume":"144","author":"M Brauckhoff","year":"2008","unstructured":"Brauckhoff M, Machens A, Hess S et al (2008) Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis. Surgery 144:1044\u20131051","journal-title":"Surgery"},{"key":"9320_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","volume":"43","author":"C Eng","year":"1995","unstructured":"Eng C, Mulligan LM, Smith DP et al (1995) Low frequency of germline mutations in the RET protooncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol 43:123\u2013127","journal-title":"Clin Endocrinol"},{"key":"9320_CR10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517\u20131525","journal-title":"N Engl J Med"},{"key":"9320_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem.82.1.3707","volume":"82","author":"VA LiVolsi","year":"1997","unstructured":"LiVolsi VA (1997) C cell hyperplasia\/neoplasia. J Clin Endocrinol Metab 82:39\u201341","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0029-1211997","volume":"106","author":"A Grauer","year":"1998","unstructured":"Grauer A, Raue F, Ziegler R (1998) Clinical usefullness of a new chemoluminescent two-site immunoassy for human calcitonin. Exp Clin Endorcinol Diabetes 106:353\u2013359","journal-title":"Exp Clin Endorcinol Diabetes"},{"key":"9320_CR13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"R Cohen","year":"2000","unstructured":"Cohen R, Campos JM, Sala\u00fcn C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab 85:905\u2013918","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/328527a0","volume":"328","author":"CG Mathew","year":"1987","unstructured":"Mathew CG, Chin KS, Easton DF et al (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527\u2013528","journal-title":"Nature"},{"key":"9320_CR15","first-page":"1619","volume":"81","author":"C Romei","year":"1996","unstructured":"Romei C, Elisei R, Pinchera A et al (1996) Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab 81:1619\u20131622","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","volume":"93","author":"R Elisei","year":"2008","unstructured":"Elisei R, Cosci B, Romei C et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682\u2013687","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","volume":"238","author":"LM Mulligan","year":"1995","unstructured":"Mulligan LM, Marsh DJ, Robinson BG et al (1995) Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Int Med 238:343\u2013346","journal-title":"J Int Med"},{"key":"9320_CR18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis. JAMA 276:1575\u20131579","journal-title":"JAMA"},{"key":"9320_CR19","first-page":"1780","volume":"81","author":"K Frank-Raue","year":"1996","unstructured":"Frank-Raue K, H\u00f6ppner W, Frilling A et al (1996) Mutations of the RET proto-oncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. J Clin Endocrinol Metab 81:1780\u20131783","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR20","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","volume":"90","author":"A Machens","year":"2005","unstructured":"Machens A, Brauckhoff M, Holzhausen HJ et al (2005) Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 90:3999\u20134003","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R et al (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142:800\u2013805","journal-title":"Surgery"},{"key":"9320_CR22","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 83:487\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2005.15.531","volume":"15","author":"MA Kouvaraki","year":"2005","unstructured":"Kouvaraki MA, Shapiro SE, Perrier ND et al (2005) RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15:531\u2013544","journal-title":"Thyroid"},{"key":"9320_CR24","first-page":"273","volume":"53","author":"K Frank-Raue","year":"2007","unstructured":"Frank-Raue K, Rondot S, Schulze E et al (2007) Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab 53:273\u2013282","journal-title":"Clin Lab"},{"key":"9320_CR25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0002-9343(96)00330-0","volume":"101","author":"AM Moers","year":"1996","unstructured":"Moers AM, Lansvater RM, Schaap C et al (1996) Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family. Am J Med 101:635\u2013641","journal-title":"Am J Med"},{"key":"9320_CR26","first-page":"2415","volume":"10","author":"A Bolino","year":"1995","unstructured":"Bolino A, Schuffenecker I, Luo Y et al (1995) RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10:2415\u20132419","journal-title":"Oncogene"},{"key":"9320_CR27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","volume":"15","author":"DP Smith","year":"1995","unstructured":"Smith DP, Houghton C, Ponder BA (1995) Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 15:1213\u20131217","journal-title":"Oncogene"},{"key":"9320_CR28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787\u2013803","journal-title":"Eur J Endocrinol"},{"key":"9320_CR29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459\u20131466","journal-title":"N Engl J Med"},{"key":"9320_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03215.x","volume":"69","author":"K Frank-Raue","year":"2008","unstructured":"Frank-Raue K, Machens A, Scheuba C et al (2008) Difference in the development of medullary thyroid carcinoma among carriers of RET mutations in codon 790 and 791. Clin Endocrinol 69:259\u2013263","journal-title":"Clin Endocrinol"},{"key":"9320_CR31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H et al (2006) Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155:229\u2013236","journal-title":"Eur J Endocrinol"},{"key":"9320_CR32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s00268-006-0846-2","volume":"31","author":"JF Moley","year":"2007","unstructured":"Moley JF, Fialkowski EA (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg 31:946\u2013956","journal-title":"World J Surg"},{"key":"9320_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","volume":"158","author":"AL Giraudet","year":"2008","unstructured":"Giraudet AL, Al Ghulzan A, Auperin A et al (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 158:239\u2013246","journal-title":"Eur J Endocrinol"},{"key":"9320_CR34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ecl.2007.04.001","volume":"36","author":"DW Ball","year":"2007","unstructured":"Ball DW (2007) Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin N Am 36:823\u2013837","journal-title":"Endocrinol Metab Clin N Am"},{"key":"9320_CR35","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1210\/jc.2008-0923","volume":"94","author":"SI Sherman","year":"2009","unstructured":"Sherman SI (2009) Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. J Clin Endocrinol Metab 94:1493\u20131499","journal-title":"J Clin Endocrinol Metab"},{"key":"9320_CR36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004230050143","volume":"383","author":"F Raue","year":"1998","unstructured":"Raue F (1998) German medullary thyroid carcinoma\/multiple endocrine neoplasia registry. Langenbeck\u2018s Arch Surg 383:334\u2013336","journal-title":"Langenbeck\u2018s Arch Surg"},{"key":"9320_CR37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","volume":"88","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Ituarte PHG, Siperstein AE et al (2000) Medullary thyroid carcinoma, clinical characteristics, treatment, prognostic factors and a comparison of staging systems. Cancer 88:1139\u20131148","journal-title":"Cancer"},{"key":"9320_CR38","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","volume":"107","author":"S Roman","year":"2006","unstructured":"Roman S, Lin R, Sosa JA (2006) Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathological predictors of survival in 1252 cases. Cancer 107:2134\u20132142","journal-title":"Cancer"},{"key":"9320_CR39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2265.2006.02659.x","volume":"65","author":"JW Groot de","year":"2006","unstructured":"de Groot JW, Plukker JTM, Wolffenbuttel BHR (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol 65:729\u2013736","journal-title":"Clin Endocrinol"},{"key":"9320_CR40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5","volume":"79","author":"U Bergholm","year":"1997","unstructured":"Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132\u2013138","journal-title":"Cancer"},{"key":"9320_CR41","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","volume":"353","author":"MA Skinner","year":"2005","unstructured":"Skinner MA, Moley JA, Dilley WG et al (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2. N Engl J Med 353:1105\u20131113","journal-title":"N Engl J Med"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9320-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9320-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:01Z","timestamp":1559252761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9320"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9320-2","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}